Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial

BACKGROUND: Topical antibiotics are frequently used to treat acne vulgaris. Their prolonged use, often for longer durations than recommended, has led to antibiotic resistance in Cutibacterium acnes (C. acnes), a bacterium implicated in acne pathophysiology. Bacteriophage (phage), which specifically...

Descripción completa

Detalles Bibliográficos
Autores principales: Golembo, M., Puttagunta, S., Rappo, U., Weinstock, E., Engelstein, R., Gahali‐Sass, I., Moses, A., Kario, E., Ben‐Dor Cohen, E., Nicenboim, J., Ben David, H., Sudakov, K., Cohen, A., Bassan, M., Zak, N. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168013/
https://www.ncbi.nlm.nih.gov/pubmed/35677920
http://dx.doi.org/10.1002/ski2.93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168013/
https://www.ncbi.nlm.nih.gov/pubmed/35677920
http://dx.doi.org/10.1002/ski2.93

Ejemplares similares